OrbiMed Advisors
Latest statistics and disclosures from Orbimed Advisors's latest quarterly 13F-HR filing:
- Top 5 stock holdings are ALXN, CELG, BIIB, BSX, MRK, and represent 22.11% of Orbimed Advisors's stock portfolio.
- Added to shares of these 10 stocks: CI (+$204.57M), Clovis Oncology (+$197.03M), GILD (+$90.07M), Mylan Nv (+$65.19M), BIIB (+$52.40M), ALNY (+$44.43M), REGN (+$43.52M), Jazz Pharmaceuticals (+$42.68M), Nabriva Therapeutics (+$41.08M), CELG (+$38.13M).
- Started 15 new stock positions in Juno Therapeutics, Envision Healthcare, Immunogen Inc bond, Argenx Se, HALO, CI, Clovis Oncology, IART, Glycomimetics, Cti Biopharma. Verona Pharma Plc ads, Novus Therapeutics, Iovance Biotherapeutics, Nabriva Therapeutics, AZN.
- Reduced shares in these 10 stocks: , HCA HOLDINGS Inc (-$100.07M), PFE (-$99.00M), , BMY (-$74.46M), AET (-$64.45M), SHPGY (-$57.62M), Eagle Pharmaceuticals (-$55.65M), ACAD (-$40.19M), INCY (-$39.06M).
- Sold out of its positions in ACAD, BCR, CNC, Clearside Biomedical, COO, Eagle Pharmaceuticals, EXAS, Lion Biotechnologies, Nabriva Therapeutics Ag, Sarepta Therapeutics. Tenet Healthcare Corporation stock.
- Orbimed Advisors was a net buyer of stock by $247.08M.
- Orbimed Advisors has $9.54B in assets under management (AUM), growing by 8.14%.
Companies in the Orbimed Advisors portfolio as of June 2017 quarter
| Company (Ticker) | Portfolio Weight | Share Count | Change in Shares | Price |
|---|---|---|---|---|
| Alexion Pharmaceuticals (ALXN) | 4.94 | 3.87M | +2% | 121.67 |
| Celgene Corporation (CELG) | 4.66 | 3.43M | +9% | 129.87 |
| Biogen Idec (BIIB) | 4.64 | 1.63M | +13% | 271.36 |
| Boston Scientific Corporation (BSX) | 4.18 | 14.40M | -5% | 27.72 |
| Merck & Co (MRK) | 3.69 | 5.49M | -3% | 64.09 |
| Vertex Pharmaceuticals Incorporated (VRTX) | 2.74 | 2.03M | -6% | 128.87 |
| Eli Lilly & Co. (LLY) | 2.65 | 3.08M | -7% | 82.30 |
| Wright Medical Group Nv | 2.58 | 8.95M | -2% | 27.49 |
| Regeneron Pharmaceuticals (REGN) | 2.40 | 466770 | +23% | 491.14 |
| Agilent Technologies Inc C ommon | 2.37 | 3.81M | +5% | 59.31 |
| Amgen (AMGN) | 2.35 | 1.30M | -9% | 172.23 |
| Edwards Lifesciences (EW) | 2.28 | 1.84M | 118.24 | |
| Puma Biotechnology Inc Common Stock | 2.22 | 2.43M | +8% | 87.40 |
| Incyte Corporation (INCY) | 2.20 | 1.66M | -15% | 125.91 |
| CIGNA Corporation (CI) | 2.14 | 1.22M | NEW | 167.39 |
| Clovis Oncology | 2.07 | 2.10M | NEW | 93.63 |
| Humana (HUM) | 1.94 | 770900 | +3% | 240.62 |
| Anthem | 1.82 | 920618 | +6% | 188.13 |
| Abbvie | 1.67 | 2.20M | +5% | 72.51 |
| Johnson & Johnson (JNJ) | 1.56 | 1.12M | +27% | 132.29 |
| Gilead Sciences (GILD) | 1.54 | 2.07M | +158% | 70.78 |
| Loxo Oncology | 1.45 | 1.73M | 80.19 | |
| Aetna (AET) | 1.41 | 887900 | -32% | 151.83 |
| Array BioPharma (ARRY) | 1.24 | 14.18M | 8.37 | |
| Mylan Nv | 1.21 | 2.98M | +129% | 38.82 |
| Ironwood Pharmaceuticals (IRWD) | 1.14 | 5.76M | -20% | 18.88 |
| Intercept Pharmaceuticals In | 1.09 | 856554 | -17% | 121.07 |
| Jazz Pharmaceuticals | 1.05 | 645900 | +73% | 155.50 |
| Aerie Pharmaceuticals | 1.01 | 1.83M | +22% | 52.55 |
| SYNERGY PHARMACEUTICALS | 0.99 | 21.15M | 4.45 | |
| Thermo Fisher Scientific (TMO) | 0.98 | 534200 | 174.47 | |
| Ascendis Pharma A S | 0.98 | 3.37M | +23% | 27.76 |
| Audentes Therapeutics Inc Com stock | 0.96 | 4.80M | 19.13 | |
| Shire (SHPGY) | 0.95 | 548808 | -38% | 165.27 |
| Allergan | 0.95 | 373590 | -21% | 243.09 |
| BioMarin Pharmaceutical (BMRN) | 0.94 | 982600 | -22% | 90.82 |
| Magellan Health Services (MGLN) | 0.93 | 1.22M | +11% | 72.90 |
| Pfizer (PFE) | 0.87 | 2.46M | -54% | 33.59 |
| UnitedHealth (UNH) | 0.83 | 428600 | +44% | 185.42 |
| Insys Therapeutics | 0.82 | 6.17M | 12.65 | |
| Medtronic | 0.82 | 879000 | +14% | 88.75 |
| Allergan Plc pfd conv ser a | 0.80 | 88200 | 867.41 | |
| Insmed Inc | 0.79 | 4.39M | -8% | 17.16 |
| Mallinckrodt Pub | 0.79 | 1.67M | +13% | 44.81 |
| Glaukos | 0.76 | 1.74M | 41.47 | |
| Illumina (ILMN) | 0.72 | 398500 | +23% | 173.52 |
| Corvus Pharmaceuticals | 0.68 | 5.38M | 12.10 | |
| Viewray | 0.64 | 9.46M | 6.47 | |
| Achillion Pharmaceuticals (ACHN) | 0.63 | 13.11M | 4.59 | |
| Global Blood Therapeutics In | 0.62 | 2.17M | +100% | 27.35 |
| Beigene | 0.61 | 1.29M | +42% | 45.00 |
| Select Medical Holdings Corporation (SEM) | 0.59 | 3.69M | +76% | 15.35 |
| Gw Pharmaceuticals Plc ads | 0.59 | 561071 | +17% | 100.25 |
| Immunomedics Inc note 4.750% 2/1 | 0.58 | 30.00M | 1.83 | |
| HCA HOLDINGS Inc | 0.55 | 597400 | -65% | 87.20 |
| Alnylam Pharmaceuticals (ALNY) | 0.53 | 639200 | +677% | 79.76 |
| Bristol Myers Squibb (BMY) | 0.51 | 874700 | -60% | 55.72 |
| Intuitive Surgical (ISRG) | 0.47 | 48200 | -4% | 935.37 |
| Stryker Corporation (SYK) | 0.46 | 316300 | 138.78 | |
| Immunomedics (IMMU) | 0.46 | 4.93M | +300% | 8.83 |
| Intellia Therapeutics Inc Com stock | 0.45 | 2.66M | 16.00 | |
| Bluebird Bio | 0.44 | 399800 | +40% | 105.05 |
| Dermira | 0.43 | 1.42M | +38% | 29.14 |
| Nabriva Therapeutics | 0.43 | 3.92M | NEW | 10.48 |
| Nevro | 0.41 | 526300 | +576% | 74.43 |
| Pieris Pharmaceuticals | 0.39 | 7.26M | 5.06 | |
| Selecta Biosciences | 0.38 | 1.84M | 19.86 | |
| Envision Healthcare | 0.38 | 578100 | NEW | 62.67 |
| Momenta Pharmaceuticals (MNTA) | 0.37 | 2.11M | 16.90 | |
| eHealth (EHTH) | 0.36 | 1.83M | 18.80 | |
| Radius Health | 0.33 | 704100 | 45.23 | |
| Otonomy | 0.31 | 1.56M | -15% | 18.85 |
| ImmunoGen (IMGN) | 0.29 | 3.94M | -35% | 7.11 |
| Juno Therapeutics | 0.29 | 915208 | NEW | 29.89 |
| Steadymed Ltd shs | 0.28 | 4.25M | +38% | 6.30 |
| Iovance Biotherapeutics | 0.26 | 3.38M | NEW | 7.45 |
| Integra LifeSciences Holdings (IART) | 0.24 | 426910 | NEW | 54.51 |
| Galapagos Nv-spon | 0.23 | 283500 | 76.52 | |
| Obseva Sa | 0.23 | 2.61M | 8.55 | |
| SINOVAC BIOTECH LTD Com | 0.19 | 2.67M | 6.75 | |
| Assembly Biosciences | 0.19 | 888426 | -29% | 20.65 |
| Dbv Technologies S A | 0.19 | 512900 | 35.71 | |
| Immunogen Inc bond | 0.19 | 10.00M | NEW | 1.83 |
| Teva Pharmaceutical Industries (TEVA) | 0.18 | 526300 | +27% | 33.22 |
| Vanda Pharmaceuticals (VNDA) | 0.17 | 967859 | +1828% | 16.30 |
| Xencor | 0.17 | 747244 | -11% | 21.11 |
| Cti Biopharma | 0.17 | 5.00M | NEW | 3.31 |
| Coherus Biosciences | 0.16 | 1.08M | 14.35 | |
| Novus Therapeutics | 0.16 | 2.54M | NEW | 5.85 |
| Natera | 0.15 | 1.28M | 10.86 | |
| Neurocrine Biosciences (NBIX) | 0.14 | 284841 | -35% | 46.00 |
| Newlink Genetics Corporation | 0.14 | 1.85M | -15% | 7.35 |
| Proqr Thrapeutics N V shs euro | 0.13 | 2.31M | 5.20 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.13 | 15.00M | 0.82 | |
| Wright Medical Group Rtsn V | 0.13 | 8.68M | +25% | 1.46 |
| Aurinia Pharmaceuticals | 0.12 | 1.80M | 6.13 | |
| Argenx Se | 0.11 | 500000 | NEW | 21.21 |
| AstraZeneca (AZN) | 0.09 | 250000 | NEW | 34.09 |
| Alkermes Plc | 0.09 | 145000 | 57.97 | |
| Heron Therapeutics | 0.09 | 650000 | 13.85 | |
| Adaptimmune Therapeutics | 0.09 | 1.91M | 4.49 | |
| Dimension Therapeutics | 0.08 | 5.40M | 1.45 | |
| Verona Pharma Plc ads | 0.08 | 666666 | NEW | 11.66 |
| Zimmer Holdings (ZMH) | 0.07 | 49000 | 128.41 | |
| D Fluidigm Corp Del | 0.07 | 1.75M | 4.04 | |
| Fluidigm Corporation convertible cor | 0.07 | 10.00M | 0.63 | |
| Syndax Pharmaceuticals | 0.06 | 437000 | -9% | 13.97 |
| Aeglea Biotherapeutics | 0.06 | 1.47M | 3.85 | |
| Crispr Therapeutics Ag | 0.06 | 372191 | 16.02 | |
| NuVasive (NUVA) | 0.05 | 65600 | -46% | 76.92 |
| Halozyme Therapeutics (HALO) | 0.05 | 350000 | NEW | 12.82 |
| Infinity Pharmaceuticals (INFI) | 0.05 | 3.25M | 1.57 | |
| Redhill Biopharma Ltd cmn | 0.05 | 564900 | 8.62 | |
| Sientra | 0.05 | 483347 | -7% | 9.72 |
| Invitae | 0.05 | 456666 | 9.56 | |
| Sierra Oncology | 0.05 | 3.70M | 1.17 | |
| Valeant Pharmaceuticals Int (VRX) | 0.04 | 194900 | 17.30 | |
| Tesaro | 0.04 | 30301 | -35% | 139.86 |
| Glycomimetics | 0.04 | 337588 | NEW | 11.16 |
| Affimed Therapeutics B V | 0.04 | 1.80M | -10% | 2.05 |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.04 | 7.00M | 0.61 | |
| Minerva Neurosciences | 0.03 | 344173 | -51% | 8.85 |
| Orexigen Therapeutics Inc note 2.750%12/0 added | 0.03 | 5.21M | 0.47 | |
| Xenon Pharmaceuticals | 0.02 | 634812 | 3.15 | |
| Cellectis S A sponsored ads | 0.02 | 66799 | -80% | 25.82 |
| Roka Bioscience | 0.02 | 893470 | 2.58 | |
| Amarin Corporation (AMRN) | 0.01 | 204857 | -41% | 4.03 |
| Biolinerx Ltd-spons Adr | 0.01 | 1.04M | 0.85 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.01 | 500000 | 1.11 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.01 | 500000 | 1.20 | |
| Marinus Pharmaceuticals | 0.01 | 567600 | 1.37 | |
| Noveliontherapeutics | 0.01 | 100000 | 9.23 | |
| Alimera Sciences (ALIM) | 0.00 | 250000 | 1.39 | |
| Xtant Med Holdings | 0.00 | 475439 | 0.66 | |
| Medigus Ltd sponsord | 0.00 | 60000 | 2.18 |
Download CSV 
Past 13F-HR SEC Filings by Orbimed Advisors
- Orbimed Advisors 2017 Q1 filed May 15, 2017
- Orbimed Advisors 2016 Q4 filed Feb. 14, 2017
- Orbimed Advisors 2016 Q3 filed Nov. 14, 2016
- Orbimed Advisors 2016 Q2 filed Aug. 15, 2016
- Orbimed Advisors 2016 Q1 filed May 16, 2016
- Orbimed Advisors 2015 Q4 filed Feb. 16, 2016
- Orbimed Advisors 2015 Q3 amended filed Nov. 18, 2015
- Orbimed Advisors 2015 Q3 filed Nov. 13, 2015
- Orbimed Advisors 2015 Q2 amended filed Aug. 20, 2015
- Orbimed Advisors 2015 Q1 filed May 15, 2015
- Orbimed Advisors 2014 Q4 filed Feb. 13, 2015
- Orbimed Advisors 2014 Q3 filed Nov. 14, 2014
- Orbimed Advisors 2014 Q2 filed Aug. 14, 2014
- Orbimed Advisors 2014 Q1 filed May 15, 2014
- Orbimed Advisors 2013 Q4 filed Feb. 14, 2014
- Orbimed Advisors 2013 Q3 filed Nov. 14, 2013
- Orbimed Advisors 2013 Q2 filed Aug. 14, 2013
- OrbiMed Advisors 2013 Q1 filed May 15, 2013
- OrbiMed Advisors 2012 Q4 amended filed April 17, 2013